Episode 076: Management of primary refractory diffuse large B-cell lymphoma (DLBCL)

This week, we pick up on our discussion about management of DLBCL, focusing on the primary refractory setting. A big part of this discussion is the role of CAR-T therapy. If you have not done so already, we highly recommend you check out episode 075 for the fundamentals of CAR-T before proceeding with this episode! Content: - Definitions for "primary refractory" vs. "relapsed" disease - How do we approach patients with primary refractory disease? - What are the treatment regimens for patients with primary refractory disease? - What is the role of CAR-T therapy? - How do we "bridge" patients to CAR-T therapy? - How do we monitor patients post CAR-T? ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Google Podcast